Press Enter to Search or ESC to Close
The landscape of metabolic medicine is experiencing a major shift as pharmaceutical researchers move beyond single-target therapies toward multi-hormone mechanisms. At the forefront of...
Education
Speaking at a press conference in Washington, D.C., Vance, who serves as the chair of the administration’s task...
Business and Finance
In a quiet corner of central Florida, a woman named Coretta sits at her kitchen table, the steam...
Health and Wellness
In the quest to understand human health and disease, the liver remains one of the most challenging frontiers....
The landscape of metabolic medicine is experiencing a major shift as pharmaceutical researchers move beyond single-target therapies toward multi-hormone mechanisms. At the forefront of this evolution is retatrutide, an experimental next-generation obesity treatment currently under development by pharmaceutical giant Eli Lilly. Retatrutide represents a significant structural and functional departure from existing anti-obesity and diabetes therapies. […]
